AKT1 and melanoma: In melanoma, pharmacological inhibition of PI3K has been shown to subdue TNF-driven sphere formation abilities from the cells, suggesting that PI3K/AKT signaling might mediate the inhibition of melanoma differentiation induced by pro-inflammatory pathways [60].